Emily Sortor  |  September 25, 2018

Category: Legal News

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Florida Patient Joins Taxotere Chemo Hair Loss LitigationA Florida breast cancer patient is joining a Taxotere chemomultidistrict litigation (MDL), alleging that the drug caused her to permanently lose her hair. She says that the drug’s manufacturer warned patients of the risk of temporary hair loss when taking Taxotere, but not of permanent hair loss.

Plaintiff Theresa B. says that she was diagnosed with breast cancer, and was treated with the chemotherapy drug Taxotere between April and September 2011 in her home state of Florida. She says that she experienced significant hair loss after taking Taxotere, and to date, her hair has not grown back to the same level and quality it had before she started chemotherapy.

Theresa claims that she was physically and emotionally injured by her hair loss she experienced from Taxotere, and aims to hold the drug’s makers, Sanofi-Aventis U.S., as well as its distributors responsible for her alleged injury. She seeks damages to compensate for the injury she claims she suffered from the drug and the company’s misrepresentations of it.

According to the Taxotere chemo lawsuit, Theresa was notified that Taxotere could cause permanent hair loss, as is the case with many chemotherapy drugs. However, she says that she was not warned that the drug could cause permanent hair loss because the company actively concealed this information from medical professionals and patients.

Theresa says that had she known that the drug could cause permanent hair loss, she would not have agreed to take the drug, and would have chosen another chemotherapy treatment.

Theresa says that she was emotionally, physically, and financially injured by Sanofi-Aventis’s alleged misrepresentations of the drug. She says that she was physically injured because her body was damaged insect a way that caused her to not be able to grow hair after taking Taxotere.

According to Theresa, the trauma of having cancer and undergoing treatment was enhanced by the emotional trauma and embarrassment of losing her hair, because it was an element that was personal and part of her identity. She says that she also incurred financial injury because she spent money and effort to try to regrow her hair and cover up the fact that she suffered hair loss.

The Taxotere chemo hair loss lawsuit says that Sanofi-Aventis knew or should have known that Taxotere caused permanent hair loss, but intentionally concealed that information from the public. The Taxotere permanent hair loss lawsuit says that the drug was initially approved by the FDA in 1998, at which point a warning accompanied the drug that said that the drug could cause temporary hair loss, that usually reversed when chemotherapy stopped.

Allegedly, it was not until 2015 that Sanofi-Aventis submitted information to the FDA that the drug could case “permanent or irreversible alopecia” (hair loss). The Taxotere chemo hair loss lawsuit suggests that the company was negligent in reporting the information that the drug could cause permanent hair loss, because the company conducted studies of the drug even after it was initially released onto the market, and failed to report findings to the FDA in a timely manner.

The Taxotere Chemo Hair Loss Lawsuit is Case No. 2:16-md-02740-KDE-MBN, in the U.S. District Court for the Eastern District of Louisiana.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Taxotere class action lawsuit is best for you. [In general, Taxotere lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.


Get Help – It’s Free

Join a Free Taxotere Class Action Lawsuit Investigation

If you received intravenous chemotherapy treatment for breast cancer and were told that your hair would grow back but it never did, you may have a legal claim. Permanent hair loss is defined as a minimum of 6 months after the Taxotere chemotherapy treatment ended, and there is still no new hair growth. Join this free Taxotere class action lawsuit investigation now!

An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.

PLEASE NOTE: If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client or getting you dropped as a client.

Oops! We could not locate your form.

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.